K, K., S, M., Y, O., S, Y., A, W., H, T., . . . Y, O. (2026). Optimized Flow Cytometry Incorporating t-SNE Enables Minimal Residual Disease Assessment in a Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia at or Near the Lower Detection Limit. Journal of pediatric hematology/oncology, 48(1), e21. https://doi.org/10.1097/MPH.0000000000003142
Chicago Style (17th ed.) CitationK, Kobayashi, et al. "Optimized Flow Cytometry Incorporating T-SNE Enables Minimal Residual Disease Assessment in a Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia at or Near the Lower Detection Limit." Journal of Pediatric Hematology/oncology 48, no. 1 (2026): e21. https://doi.org/10.1097/MPH.0000000000003142.
MLA (9th ed.) CitationK, Kobayashi, et al. "Optimized Flow Cytometry Incorporating T-SNE Enables Minimal Residual Disease Assessment in a Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia at or Near the Lower Detection Limit." Journal of Pediatric Hematology/oncology, vol. 48, no. 1, 2026, p. e21, https://doi.org/10.1097/MPH.0000000000003142.